Zynex Inc. (ZYXI) News

Zynex Inc. (ZYXI): $10.52

0.23 (+2.24%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

A

Add ZYXI to Watchlist
Sign Up

Industry: Medical - Consumer Goods

Industry

A

Ranked

#4 of 10

in industry

Filter ZYXI News Items

ZYXI News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ZYXI News Highlights

  • For ZYXI, its 30 day story count is now at 2.
  • Over the past 7 days, the trend for ZYXI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest ZYXI News From Around the Web

Below are the latest news stories about ZYNEX INC that investors may wish to consider to help them evaluate ZYXI as an investment opportunity.

Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum

The post Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum appeared first on CorpGov.

Yahoo | December 15, 2023

12 Best Healthcare Stocks For the Long-Term

In this piece, we will take a look at the 12 best healthcare stocks for the long term. If you want to skip our overview of the healthcare industry, then you can take a look at 5 Best Healthcare Stocks For the Long-Term. The healthcare industry is one of the biggest industries in the world. […]

Yahoo | December 8, 2023

Healthcare Edge: Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum

Healthcare Edge and Exec Edge are please to provide complete video coverage of the third annual Palm Beach CorpGov Forum, which was held on Nov. 8, featuring a full day of panels and fireside chats. The event was composed of over 200 attendees including public and private corporations, private equity and VC funds, institutions, family offices, attorneys, investment bankers, other […]

Yahoo | November 27, 2023

Zynex Ranked in Forbes List of "America's Most Successful Small-Cap Companies 2024"

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked within Forbes' list of America's Most Successful Small-Cap Companies for 2024. The 2024 Forbes list of America's Most Successful Small-Cap Companies can be found at www.forbes.com.

Yahoo | November 15, 2023

Zynex Submits FDA Application for its Next Generation NMES Device

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the M-Wave Neuromuscular Electrical Stimulation ("NMES") device.

Yahoo | November 13, 2023

Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked among all companies in the U.S. and Canada between 2019 and 2022 on Deloitte's Technology Fast 500. Zynex's revenues grew 248% over that period, with 2022 revenue reaching $158.2 million. The company estimates 2023 revenue between $189.5 and $194.5 mill

Yahoo | November 9, 2023

Zynex (NASDAQ:ZYXI) shareholders have earned a 27% CAGR over the last five years

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Yahoo | November 6, 2023

EXCLUSIVE: Medical Devices Firm Zynex Launches New $20M Share Repurchase Program

Zynex Inc's (NASDAQ: ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than November 1, 2024, or when the $20.0 million limit is reached. Tuesday, Zynex initiated a process to evaluate potential strategic alternatives, confirming a Bloomberg report from Monday. It has retained Cantor Fitzgerald & Co. as its financial advisor. "Zynex recently announced strong earnings," said Thomas Sa

Yahoo | November 1, 2023

Zynex Announces Share Repurchase Program

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to repurchase up to $20.0 million of the Company's common stock. The program will commence on November 1, 2023, and is scheduled to terminate on the earlier of November 1, 2024, or when the $20.0 million limit is reached.

Yahoo | November 1, 2023

Zynex Announces Review of Strategic Alternatives

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced its Board of Directors (the "Board") has initiated a process to evaluate potential strategic alternatives to maximize shareholder value. As part of the process, the Board will evaluate, together with its advisors, a range of potential strategic alternatives which may include, any

Yahoo | October 31, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!